Type 2 & other diabetes

Understanding strategies to improve medication adherence among persons with type 2 diabetes: A scoping review

Diabet MedPublished Scoping review

Authors' conclusion

The findings from this review identify BCTs and targeted behaviours with demonstrated success. Further exploration of the myriad of BCTs and the corresponding determinants of behaviour which were not accessed may be warranted for the development of future strategies to improve medication adherence in type 2 diabetes.

Study context

Population
Adults with T2D; publications on strategies to overcome medication non-adherence (EMBASE, Ovid MEDLINE and Epub Ahead of Print, In-Process & Other Non-Indexed Citations and Daily; search 11 March 2021)58 articles · 61 strategies
Outcome
BCTs and TDF domains of strategies with statistically significant improvement in medication adherence
Methodological detailsStrategies categorized by BCT taxonomy; targeted determinants of behaviour classified by Theoretical Domains Framework (TDF)
  • Strategies categorized by BCT taxonomy; targeted determinants of behaviour classified by Theoretical Domains Framework (TDF)

Main finding

As reported in the abstract

  • BCT categories most frequent in strategies with significant improvement in adherence: Antecedents and Natural consequences
  • Behaviour change techniques (BCTs) most frequent in strategies with significant improvement in adherence: Feedback on outcome(s) of behaviour, Adding objects to the environment, Information about health consequences
  • Strategies targeting TDF domains Reinforcement and Beliefs about Consequences most often resulted in significant improvements in adherence measures

Original publication

Understanding strategies to improve medication adherence among persons with type 2 diabetes: A scoping review. Diabet Med. Published 29 September 2022. doi:10.1111/dme.14941

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.